Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: results from a pragmatic cluster randomized controlled trial.

Clouston K, Katz A, Martens PJ, Sisler J, Turner D, Lobchuk M, McClement S, Crow G; CIHR/CCMB Team in Primary Care Oncology (PCO-NET).

BMC Cancer. 2014 Apr 16;14:263. doi: 10.1186/1471-2407-14-263.

2.

Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: A pragmatic cluster randomized controlled trial study protocol.

Clouston K, Katz A, Martens PJ, Sisler J, Turner D, Lobchuk M, McClement S; CIHR/CCMB Team in Primary Care Oncology (PCO-NET).

BMC Cancer. 2012 May 17;12:182. doi: 10.1186/1471-2407-12-182.

3.
4.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.

5.

Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.

Baker DW, Brown T, Buchanan DR, Weil J, Balsley K, Ranalli L, Lee JY, Cameron KA, Ferreira MR, Stephens Q, Goldman SN, Rademaker A, Wolf MS.

JAMA Intern Med. 2014 Aug;174(8):1235-41. doi: 10.1001/jamainternmed.2014.2352.

PMID:
24934845
6.

Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.

Green BB, Anderson ML, Chubak J, Fuller S, Meenan RT, Vernon SW.

Cancer. 2016 Jan 15;122(2):312-21. doi: 10.1002/cncr.29734. Epub 2015 Oct 21.

7.

Financial incentives for completion of fecal occult blood tests among veterans: a 2-stage, pragmatic, cluster, randomized, controlled trial.

Kullgren JT, Dicks TN, Fu X, Richardson D, Tzanis GL, Tobi M, Marcus SC.

Ann Intern Med. 2014 Nov 18;161(10 Suppl):S35-43. doi: 10.7326/M13-3015.

PMID:
25402401
8.
9.

Comparing the effect of a decision aid plus patient navigation with usual care on colorectal cancer screening completion in vulnerable populations: study protocol for a randomized controlled trial.

Brenner AT, Getrich CM, Pignone M, Rhyne RL, Hoffman RM, McWilliams A, de Hernandez BU, Weaver MA, Tapp H, Harbi K, Reuland D.

Trials. 2014 Jul 8;15:275. doi: 10.1186/1745-6215-15-275.

10.

Automated telephone calls improved completion of fecal occult blood testing.

Mosen DM, Feldstein AC, Perrin N, Rosales AG, Smith DH, Liles EG, Schneider JL, Lafata JE, Myers RE, Kositch M, Hickey T, Glasgow RE.

Med Care. 2010 Jul;48(7):604-10. doi: 10.1097/MLR.0b013e3181dbdce7.

11.

Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.

Turner B, Myers RE, Hyslop T, Hauck WW, Weinberg D, Brigham T, Grana J, Rothermel T, Schlackman N.

J Gen Intern Med. 2003 May;18(5):357-63.

12.

Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.

Denis B, Broc G, Sauleau EA, Gendre I, Gana K, Perrin P.

Rev Epidemiol Sante Publique. 2017 Feb;65(1):17-28. doi: 10.1016/j.respe.2016.06.336. Epub 2017 Jan 11.

PMID:
28089385
13.

Strategies to improve repeat fecal occult blood testing cancer screening.

Davis TC, Arnold CL, Bennett CL, Wolf MS, Reynolds C, Liu D, Rademaker A.

Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):134-43. doi: 10.1158/1055-9965.EPI-13-0795. Epub 2013 Nov 5.

14.

What is the role of family in promoting faecal occult blood test screening? Exploring physician, average-risk individual, and family perceptions.

Lobchuk MM, Bapuji SB, McClement SE, Sisler JJ, Katz A, Martens P, Turner D, Clouston K.

Cancer Epidemiol. 2012 Jun;36(3):e190-9. doi: 10.1016/j.canep.2012.01.002. Epub 2012 Feb 5.

PMID:
22310235
15.

FOBT completion in FQHCs: impact of physician recommendation, FOBT information, or receipt of the FOBT kit.

Davis TC, Arnold CL, Rademaker AW, Platt DJ, Esparza J, Liu D, Wolf MS.

J Rural Health. 2012 Summer;28(3):306-11. doi: 10.1111/j.1748-0361.2011.00402.x. Epub 2012 Jan 24.

16.

A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.

Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, Cordes JE, Engelhard D.

J Natl Cancer Inst. 2004 May 19;96(10):770-80.

PMID:
15150305
17.

The effectiveness of the FLU-FOBT program in primary care a randomized trial.

Potter MB, Walsh JM, Yu TM, Gildengorin G, Green LW, McPhee SJ.

Am J Prev Med. 2011 Jul;41(1):9-16. doi: 10.1016/j.amepre.2011.03.011.

PMID:
21665058
18.

Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.

Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, Fracchia M, Gasperoni S, Malfitana G, Recchia S, Risio M, Rizzetto M, Saracco G, Spandre M, Turco D, Turco P, Zappa M; SCORE2 Working Group-Italy.

J Natl Cancer Inst. 2005 Mar 2;97(5):347-57.

PMID:
15741571
19.
20.

Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.

Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, Muñoz R, Lau C, Somsouk M, El-Nachef N, Hayward RA.

Arch Intern Med. 2012 Apr 9;172(7):575-82. doi: 10.1001/archinternmed.2012.332.

Supplemental Content

Support Center